Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001236537-25-000006
Filing Date
2025-10-16
Accepted
2025-10-16 08:15:49
Documents
1
Period of Report
2025-10-15

Document Format Files

Seq Description Document Type Size
1 form4-10162025_121046.html 4  
1 form4-10162025_121046.xml 4 3156
  Complete submission text file 0001236537-25-000006.txt   4622
Mailing Address 3030 CALLAN RD SAN DIEGO CA 92121
Business Address
MATSUI CONNIE (Reporting) CIK: 0001236537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38662 | Film No.: 251396425

Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Issuer) CIK: 0001382101 (see all company filings)

EIN.: 452441988 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)